J9022 HCPCS code: Injection, atezolizumab, 10 mg
J9022 is the HCPCS Level II code for injection, atezolizumab, 10 mg. In 2024 Medicare paid an average of $66.01 per service for J9022 across 3,084,893 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 168 per day on outpatient hospital claims. Medicare volume fell 24% from 2022 to 2024 (4,065,543 to 3,084,893 services). In 2024, about 3,049 clinicians billed Medicare for J9022 for 3,899 beneficiaries; Florida, California, Texas accounted for 32% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 2018-01-01 |
| Last action effective | 2018-01-01 |
Who bills J9022 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 3,049 |
| Medicare beneficiaries | 3,899 |
| States with claims | 41 |
| Share of services in top 3 states (Florida, California, Texas) | 32% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9022, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 4,065,543 | 5,338 | $78.84 | $62.93 |
| 2023 | 3,750,631 | 4,725 | $79.42 | $63.26 |
| 2024 | 3,084,893 | 3,899 | $82.87 | $66.01 |
States with the most J9022 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 367,261 | $66.26 |
| California | 310,496 | $65.02 |
| Texas | 303,670 | $66.64 |
| Illinois | 182,916 | $66.57 |
| Virginia | 132,708 | $66.54 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 168 | Prescribing Information |
| practitioner claims | 168 | Prescribing Information |
What changed for J9022
- 2018-01-01: J9022 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9022?
J9022 is the HCPCS Level II code for injection, atezolizumab, 10 mg. Short descriptor: "Inj, atezolizumab,10 mg".
How much does Medicare pay for J9022?
In 2024, the average Medicare payment was $66.01 per service (average allowed $82.87).
Does Medicare cover J9022?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9022 can be billed per day?
168 on outpatient hospital claims; 168 on practitioner claims (NCCI medically unlikely edits).
Related J90 codes
- J9000 — Injection, doxorubicin hydrochloride, 10 mg
- J9010 — Injection, alemtuzumab, 10 mg
- J9011 — Injection, datopotamab deruxtecan-dlnk, 1 mg
- J9015 — Injection, aldesleukin, per single use vial
- J9017 — Injection, arsenic trioxide, 1 mg
- J9019 — Injection, asparaginase (erwinaze), 1,000 iu
- J9020 — Injection, asparaginase, not otherwise specified, 10,000 units
- J9021 — Injection, asparaginase, recombinant, (rylaze), 0.1 mg
- J9023 — Injection, avelumab, 10 mg
- J9024 — Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
- J9025 — Injection, azacitidine, 1 mg
- J9026 — Injection, tarlatamab-dlle, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9022
- Watch J9022 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9022
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.